Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.71
-0.21 (-3.55%)
At close: Aug 18, 2025, 2:16 PM
Karyopharm Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -123.57M | -62.52M | -76.42M | -87.48M | -89.91M | -146.34M | -143.1M | -139.77M | -141.59M | -158.02M | -165.29M | -88.06M | -103.55M | -108.07M | -124.09M | -206.23M | -207.91M | -200.76M |
Depreciation & Amortization | -1.91M | -1.78M | -1.77M | -1.78M | 333K | 325K | 530K | 566K | 668K | 734K | 621K | 647K | 651K | 731K | 789K | 907K | 956K | 965K |
Stock-Based Compensation | 15.39M | 17.02M | 18.43M | 19.74M | 20.64M | 21.29M | 21.71M | 22.7M | 24.42M | 33.45M | 35.4M | 36.09M | 36.72M | 29.76M | 29.78M | 29.23M | 28.32M | 26.61M |
Other Working Capital | 25.07M | 14.21M | 3.21M | -334K | 4.16M | 9.08M | 9.76M | 8.23M | 7.95M | 1.07M | -15.96M | -37.94M | -29.87M | -37.32M | -9.26M | 12.98M | -686K | 6.54M |
Other Non-Cash Items | -21.27M | -84.35M | -67.42M | -67.7M | -67.48M | -8.98M | -9.19M | -1.06M | -1.35M | -1.34M | -180K | 551K | 8.19M | 8.1M | 8.13M | 10.39M | 4.87M | 6.76M |
Deferred Income Tax | n/a | n/a | n/a | 7.87M | 6.93M | 5.92M | 5.92M | -1.95M | -1.01M | n/a | n/a | 571K | 685K | 804K | 1.45M | 1.08M | 1.58M | 1.54M |
Change in Working Capital | 28.41M | 8.89M | -302K | 9.08M | -846K | 10.24M | 31.41M | 18.53M | 19.04M | 16.02M | -19.99M | -46.92M | -35.4M | -44.75M | -23.19M | 1.4M | -11.4M | -3.24M |
Operating Cash Flow | -102.94M | -122.75M | -127.49M | -120.26M | -130.34M | -117.54M | -92.72M | -100.98M | -99.82M | -109.27M | -149.55M | -97.24M | -92.82M | -113.42M | -107.12M | -163.22M | -183.58M | -168.11M |
Capital Expenditures | 53K | 53K | -142K | -195K | -195K | -195K | n/a | 79K | 40K | 40K | -39K | -325K | -291K | -291K | -212K | -124K | -119K | -135K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.71M | -11.71M | -11.71M | -11.71M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -22.31M | -27.21M | -58.82M | -73.88M | -99.14M | -130.43M | -159.15M | -239.69M | -223.52M | -250.81M | -226.02M | -128.92M | -109.52M | -55M | -45.23M | -71.89M | -103.54M | -206.46M |
Sales Maturities Of Investments | 78.1M | 115.98M | 154.44M | 181.59M | 191.69M | 192.89M | 167.09M | 155.49M | 158.72M | 128.24M | 121.88M | 120.56M | 116.87M | 145.41M | 192.78M | 220.49M | 246.13M | 242.57M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 21.17M | 21.17M | 21.09M | 32.8M | -24.96M | -38.92M | -38.34M | -56.05M | 27M | 84.14M | 115.16M | 142.59M | 36.12M |
Investing Cash Flow | 55.84M | 88.82M | 95.47M | 107.52M | 92.36M | 62.27M | 7.94M | -84.2M | -64.84M | -122.61M | -104.26M | -8.19M | 1.56M | 84.62M | 141.84M | 142.47M | 142.47M | 35.98M |
Debt Repayment | 40.52M | 80.71M | 80.71M | 40.19M | 40.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 111M | 111M | 111M | 111M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -40.52M | -40.52M | -40.52M | n/a | 38.56M | 39.42M | 39.42M | 40.59M | 2.04M | 2.51M | 3.98M | 3.71M | 3.71M | 64.44M | 63.74M | 66.84M | 68.07M | 8.35M |
Financial Cash Flow | 1.04M | 41.65M | 41.65M | 41.23M | 79.8M | 39.69M | 39.69M | 195.27M | 162.5M | 162.96M | 193.74M | 38.79M | 33.01M | 93.75M | 73.65M | 76.72M | 77.94M | 17.93M |
Net Cash Flow | -46.03M | 7.73M | 9.62M | 28.58M | 3.26M | -54.15M | -83.69M | -28.48M | -2.18M | -69.36M | -60.56M | -67.38M | -58.69M | 64.9M | 108.32M | 56.33M | 36.98M | -113.94M |
Free Cash Flow | -102.89M | -122.69M | -127.63M | -120.46M | -130.53M | -117.73M | -92.72M | -100.9M | -99.78M | -109.23M | -149.59M | -97.56M | -93.11M | -113.72M | -107.33M | -163.35M | -183.7M | -168.25M |